Bliss GVS Pharma Ltd. benchmarking: Performance to industry peers

Financial

	Bliss GVS Pharma	Orchid Pharma	Zota Health Care
Operational Metrics
Pharmaceuticals
R&D as a % of Total Sales	2.7 %	n/a	0.04 %
Financials
5 yr Average ROE	7.3 %	4.49 %	1.99 %
5yr average Equity Multiplier	1.28	1.61	1.84
5yr Average Asset Turnover Ratio	0.64	0.5	0.91
5yr Avg Net Profit Margin	9.12 %	0.56 %	-4.95 %
Price to Book	4.38	3.79	6.94
P/E	40.45	237.7	0.0
5yr Avg Cash Conversion Cycle	156.82 Days	52.03 Days	40.5 Days
Inventory Days	53.4 Days	112.47 Days	91.82 Days
Days Receivable	180.13 Days	86.58 Days	42.2 Days
Days Payable	72.69 Days	159.29 Days	92.36 Days
5yr Average Interest Coverage Ratio	14.96	3.01	5.98
5yr Avg ROCE	14.01 %	3.08 %	-2.72 %
5yr Avg Operating Profit Margin	16.55 %	11.84 %	3.69 %
5 yr average Debt to Equity	0.08	0.37	0.04
5yr CAGR Net Profit	53.73 %	n/a	206.06 %
5yr Average Return on Assets	5.79 %	1.2 %	-3.4 %
Shareholdings
Promoter Holding	35.36 %	69.84 %	49.38 %
Share Pledged by Promoters	0.0	0.0	0.26 %
Change in Promoter Holding (3 Yrs)	0.32 %	-20.12 %	-18.74 %
Change in Mutual Fund Holding (3 Yrs)	0.0	16.98 %	0.37 %

	Bliss GVS Pharma	Orchid Pharma	Zota Health Care
Product Wise Break-Up	Product Wise Break-Up Anti Malarials 43.0 Anti-fungal 16.0 Anti Inflammatory 7.0 Antibiotics 5.0 Anti-bacterial 0 Sterile 0 Oral Formulations 0 Retail Pharmacy 0 Export 0 0 Others 29.0	Product Wise Break-Up Antibiotics 0 Anti-fungal 0 Retail Pharmacy 0 Anti Malarials 0 Export 0 Oral Formulations 72.44 Anti Inflammatory 0 Sterile 27.56 Anti-bacterial 0 0	Product Wise Break-Up Antibiotics 0 Anti-fungal 0 Pharmacy 63.56 Anti Malarials 0 Export 10.89 Oral Formulations 0 Anti Inflammatory 0 Sterile 0 Anti-bacterial 0 Marketing 21.65 Others 3.9
Location Wise Break-Up	Location Wise Break-Up Rest of the World 93.39 India 6.61	Location Wise Break-Up Rest of the World 0 India 19.9 Others 80.1	Location Wise Break-Up Rest of the World 6.0 India 94.0